Skip to content

A randomized double-blind controlled study for the evaluation of the clinical efficacy of the Tibetan medicine 'Fifteen Weisaierdou Pills'

A randomized double-blind controlled study for the evaluation of the clinical efficacy of the Tibetan medicine 'Fifteen Weisaierdou Pills'

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003470
Enrollment
Unknown
Registered
2020-07-06
Start date
2020-09-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

silt-type gallstones

Interventions

Sponsors

Qinghai Jiumei Tibetan Medicine Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) "Consensus Opinions on Medical Diagnosis and Treatment of Chronic Cholecystitis and Cholecystolithiasis in China" (2018) Sand-type gallbladder Stone diagnostic criteria; (2) It meets the diagnostic criteria of Tibetan medicine and is hot, with more than 5 clinical symptoms; (3) The age range is 20-70 years old; (4) Those who voluntarily participated in the research and signed the informed consent.

Exclusion criteria

Exclusion criteria: (1) Exclude patients with acute non-calculous cholecystitis, gallbladder polyps, gallbladder cancer, gastric ulcers, gastric erosion, etc. with severe stomach disease; (2) Combined with other diseases, such as severe heart, brain, kidney, lung dysfunction and trauma; (3) Pregnant women and lactating women. (4) Have not taken other Chinese and Western medicines for treating cholecystitis within 15 days, such as Xiaoyanlidan tablets; (5) Circumstances that other researchers think are not suitable for participating in the research.

Design outcomes

Primary

MeasureTime frame
recurrence rate;Stone discharge time ;

Countries

China

Contacts

Public ContactKaxian Cairang
2731435914@qq.com+86 15297189073

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026